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Abstract. 
 
We have expressed dominant-active and 
dominant-negative forms of the Rho GTPases, Cdc42 
and Rac, using vaccinia virus to evaluate the effects of 
these mutants on the signaling pathway leading to the 
degranulation of secretory granules in RBL-2H3 cells. 
Dominant-active Cdc42 and Rac enhance antigen-stim-
ulated secretion by about twofold, whereas the domi-
nant-negative mutants signiﬁcantly inhibit secretion. 
Interestingly, treatment with the calcium ionophore, 
A23187, and the PKC activator, PMA, rescues the in-
hibited levels of secretion in cells expressing the domi-
nant-negative mutants, implying that Cdc42 and Rac 
act upstream of the calcium inﬂux pathway. Further-
more, cells expressing the dominant-active mutants ex-
 
hibit elevated levels of antigen-stimulated IP
 
3
 
 produc-
tion, an ampliﬁed antigen-stimulated calcium response 
consisting of both calcium release from internal stores 
and inﬂux from the extracellular medium, and an in-
crease in aggregate formation of the IP
 
3
 
 receptor. In 
contrast, cells expressing the dominant-negative mu-
tants display the opposite phenotypes. Finally, we are 
able to detect an in vitro interaction between Cdc42 
 
and PLC
 
g
 
1, the enzyme immediately upstream of IP
 
3
 
 
formation. Taken together, these ﬁndings implicate 
Cdc42 and Rac in regulating the exocytosis of secretory 
granules by stimulation of IP
 
3
 
 formation and calcium 
mobilization upon antigen stimulation.
Key words: Cdc42p • Rac • calcium signaling • de-
granulation • signal transduction
 
Introduction
 
Antigen stimulation of the IgE receptor, Fc
 
e
 
RI, triggers a
signal transduction cascade leading to the degranulation of
preformed secretory granules containing a variety of po-
tent inflammatory mediators in mast cells and basophils
during the allergic response. The initial stimulus, aggrega-
tion of IgE bound to Fc
 
e
 
RI in response to multivalent
ligand, elicits the phosphorylation of Fc
 
e
 
RI by the tyrosine
kinase, Lyn, recruitment of the kinase, Syk, to the plasma
membrane, and subsequent phosphorylation and activa-
tion of many signaling proteins, including phosphatidyl-
inositol 3-kinase (PI3-K)
 
1
 
, the guanine nucleotide ex-
change factor Vav, focal adhesion kinase (FAK), and
phospholipase C-
 
g
 
 (PLC
 
g
 
; for review, see Beaven and
Baumgartner, 1996). Activated PLC
 
g
 
 cleaves the mem-
brane-bound lipid phosphatidylinositol-4,5-bisphosphate
(PIP
 
2
 
-4,5) into diacylglycerol, a stimulator of protein ki-
nase C (PKC), and inositol 1,4,5-trisphosphate (IP
 
3
 
), the
ligand for the IP
 
3
 
 receptor calcium channel in the ER
membrane (for review, see Berridge, 1993). Binding of IP
 
3
 
to its receptor releases the intraluminal calcium from the
ER into the cytoplasm, which in turn causes the influx
of extracellular calcium into the cell through the I
 
CRAC
 
plasma membrane calcium channel (Hoth and Penner,
1992). The combination of both PKC activation and the in-
crease in intracellular calcium is sufficient for promoting
the targeting and fusion of secretory granules with the cell
surface (Katakami et al., 1984; Sagi-Eisenberg et al., 1985).
A role for GTP-binding proteins in the signaling cascade
leading to degranulation was originally put forth based on
the observation that treatment of permeabilized mast cells
with the nonhydrolyzable analogue, GTP
 
g
 
S, activated se-
cretion, implying the involvement of either heterotrimeric
or small G proteins, or both, in the secretory response
(Howell et al., 1987). Introduction of inhibitory or stimula-
tory peptides into mast cells have implicated both the het-
erotrimeric G protein, G
 
i3
 
 (Aridor et al., 1993), and the
small G protein, Rab3 (Oberhauser et al., 1992), in the lat-
ter stages of membrane fusion during exocytosis.
Several lines of evidence have suggested that members
of the Rho family of small GTP-binding proteins, Cdc42,
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Rac, and Rho, also participate in regulating degranulation
in mast cells and RBL-2H3 cells, a well-characterized rat
mucosal mast cell line. First, secretion efficiency in perme-
abilized mast cells was enhanced upon incubation with re-
combinant activated forms of Rho and Rac and reduced
under conditions that inhibit Rho and Rac activity (Price
et al., 1995; Norman et al., 1996). In a similar system, re-
combinant Rac and Cdc42 were shown to delay the onset
of the progressive decrease in secretion efficiency nor-
mally observed after streptolysin-
 
O
 
 treatment (Brown et al.,
1998). The ability to retard the gradual loss of responsive-
ness to stimulation indicated that Rac and Cdc42 were
able to functionally replace proteins that had diffused out
of the permeabilized cell, either as regulators or direct
components of degranulation. A Rac/RhoGDI complex
purified from bovine brain cytosol was also found to re-
tard the loss of the secretory response (O’Sullivan et al.,
1996). However, when RhoGDI, a guanine nucleotide dis-
sociation inhibitor that negatively regulates the Rho fam-
ily of GTP-binding proteins, was introduced separately,
exocytosis was inhibited (Mariot et al., 1996).
Second, stable expression of the dominant-negative
forms of Cdc42 and Rac in RBL-2H3 cells inhibited anti-
gen-induced degranulation and displayed different effects
on cell morphology (Guillemot et al., 1997). The Rho fam-
ily has been implicated in playing critical regulatory roles
in cell motility, morphology, and cytoskeletal reorganiza-
tion (for review, see Hall, 1998). Studies examining the re-
distribution of actin filaments from the cortical region to
the cell interior upon antigen stimulation suggested that
Rho and Rac mediate the concomitant changes in cell
shape and actin reorganization during degranulation in
mast cells (Norman et al., 1996).
Third, treatment of RBL-2H3 cells with 
 
Clostridium dif-
ficile
 
 toxin B, which modifies RhoA and Cdc42 by mono-
glucosylation, completely blocked degranulation. In con-
trast, degranulation was unaffected in cells treated with
 
Clostridium botulinum 
 
C3 transferase, which selectively
impairs RhoA, thus implying that toxin B inhibited exocy-
tosis by inactivating Cdc42 (Prepens et al., 1996).
To further define at which step in the signaling cascade
or the exocytosis process the Rho proteins may be acting,
we have constructed a vaccinia virus expression system to
produce dominant-active and dominant-negative mutants
of Cdc42 and Rac. Using a vaccinia virus infection scheme
offers several advantages over the strategies that have
been previously used to investigate degranulation. The in-
fection process maintains an in vivo state and avoids the
cell membrane disruption and subsequent leakage of solu-
ble protein inherent in the permeabilized cell system.
Permanently transformed cell lines expressing dominant-
active or dominant-negative mutants are difficult to prop-
agate, most likely owing to the many critical cellular func-
tions mediated by the GDP/GTP cycling of the GTPases.
Thus, the transient nature of viral infection over the
course of several hours circumvents the continual overex-
pression of cytotoxic proteins in stable cell lines. Proteins
expressed by vaccinia virus are properly modified and lo-
calized in the cell, an important requirement for activity
since Rho family members are dependent on a lipid modi-
fication for proper membrane localization. Finally, apply-
ing a high multiplicity of infection ensures uniform expres-
 
sion levels within a whole cell population, hence leading to
more consistent effects in biological assays.
Using this system, we have confirmed that activation of
Cdc42 and Rac participates in Fc
 
e
 
RI-mediated activation
of degranulation and have traced a role for the GTPases to
an early step in the signaling cascade. We demonstrate
that Cdc42 and Rac can regulate the production of the sec-
ond messenger IP
 
3
 
 and the consequent rise in intracellular
calcium required for exocytosis. Furthermore, we have de-
tected an in vitro biochemical interaction between acti-
vated Cdc42 and PLC
 
g
 
1, suggesting that the small GTP-
ases may feed into the signal transduction pathway at the
level of PLC
 
g
 
1 and the production of IP
 
3
 
.
 
Materials and Methods
 
Cells and Reagents
 
The RBL-2H3 cell line, IgE, and DNP/BSA were gifts from B. Baird and
D. Holowka (Cornell University, Ithaca, NY). RBL cells were maintained
in monolayer culture in MEM (Life Technologies) supplemented with
20% fetal bovine serum (Atlanta Biologicals, Inc.), 2% 
 
L
 
-glutamine (Life
Technologies) and 50 
 
m
 
g/ml gentamicin sulfate (Sigma) at 37
 
8
 
C in a 5%
CO
 
2
 
 incubator. Cells were harvested with 0.05% trypsin, 0.53 M EDTA·
4Na (Life Technologies). Experiments were generally performed 3–4 d af-
ter passage.
 
Construction of Recombinant Vaccinia Viruses and 
Infection Procedure
 
Wild-type and mutant forms of Cdc42 and Rac bearing a myc-tag at the
NH
 
2
 
 terminus were cloned into pSC65 (a gift from B. Moss, NIH) using
the SalI and XmaI restriction sites. Screening, isolation and amplification
of the recombinant viruses were performed essentially as described (Chen
and Padmanabhan, 1997) with the following exceptions. During construc-
tion of the recombinant virus, the pSC65 constructs bearing Cdc42 and
Rac were transfected into CV-1 cells using LipofectAMINE reagent (Life
Technologies). Infected cells were incubated with 0.33 mg/ml X-Gal dur-
ing the screening procedure to detect viruses that had successfully incor-
porated the LacZ marker gene from pSC65 into the viral genome. Identi-
fication of viruses expressing recombinant protein was confirmed by
performing Western blots on lysates of infected Hutk-143B cells with the
anti-myc 9E10 antibody (American Type Culture Collection). Viruses
that exhibited a high level of expression were further amplified in HeLa
cells and stored in small aliquots at 
 
2
 
80
 
8
 
C. Titers of amplified viral stocks
generally ranged from 10
 
6–
 
10
 
7
 
 pfu/
 
m
 
l.
RBL-2H3 cells were infected with recombinant vaccinia virus at 20 pfu/
cell in MEM media supplemented with 5% fetal bovine serum, 2%
glutamine, 50 
 
m
 
g/ml gentamicin sulfate, and 1 
 
m
 
g/ml IgE for 6–7 h. Before
infection, viruses were sonicated briefly, incubated with an equal volume
of 0.25 mg/ml trypsin in 0.9% NaCl (Sigma) for 30 min at 37
 
8
 
C, and reson-
icated to disrupt aggregates of viruses that had formed during storage at
 
2
 
80
 
8
 
C.
 
Cell Lysis, Immunoblotting, and GST
Binding Experiments
 
RBL-2H3 cells were washed with phosphate-buffered saline and lysed in
buffer A (40 mM Hepes, pH 7.4, 1% Triton X-100, 1 mM EDTA, 150 mM
NaCl, 50 mM NaF, 1 mM sodium orthovanadate, 10 
 
m
 
g/ml leupeptin, 10
 
m
 
g/ml aprotinin, and 1 mM PMSF) by rocking for 30 min at 4
 
8
 
C. Lysates
were precleared by centrifugation at 12,000 
 
g
 
 for 5 min and solubilized by
boiling for 3 min in SDS sample buffer. Whole cell lysates were then re-
solved by SDS-PAGE and transferred to Immobilon
 
 P 
 
membranes (Milli-
pore). For Western blot detection, the following primary antibodies were
used at 1:1,000 dilution: rabbit anti-Cdc42 (Erickson et al., 1996), mouse
anti-Rac (Santa Cruz Biotechnology), mouse anti-myc 9E10, rabbit anti-
PLC
 
g
 
1-1249 (Santa Cruz Biotechnology), and rabbit anti-IQGAP (a gift
from M. Hart, Onyx Pharmaceuticals). Blots were developed using either
sheep anti–rabbit or sheep anti–mouse coupled to horseradish peroxidase
at a dilution of 1:10,000 and the ECL detection system (Amersham Corp.). 
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GST alone, GST fused to the limit Cdc42/Rac (p21)-binding domain
from PAK3 (GST-PBD), and GST fusions to the wild-type and mutant
forms of Cdc42 were expressed in 
 
E
 
.
 
 coli
 
 and purified by affinity binding
to agarose beads cross-linked to glutathione (Hart et al., 1994). Immobi-
lized GST-PBD (
 
z
 
50 
 
m
 
g) was incubated with RBL-2H3 cell lysates for 1 h
at 4
 
8
 
C, and precipitates were then washed three times with buffer A.
Bound proteins were eluted by boiling in SDS sample buffer and sub-
jected to Western blot analysis with the anti-myc antibody. Immobilized
GST alone, GST-Cdc42, GST-Cdc42
 
L61
 
, and GST-Cdc42
 
N17
 
 (
 
z
 
50 
 
m
 
g)
were incubated in 10 mM Tris-Cl, pH 7.5, 100 mM NaCl, 10 mM EDTA,
and 1 mM PMSF for 15 min at room temperature to release prebound nu-
cleotide, loaded with 0.5 mM GTP
 
g
 
S for 30 min at room temperature, and
supplemented with 10 mM MgCl
 
2
 
. The GST proteins were then incubated
with lysates generated from either nonstimulated RBL-2H3 cells or cells
stimulated for 5 min with 100 ng/ml DNP/BSA for 1 h at 4
 
8
 
C in buffer B
(10 mM Tris-Cl, pH 7.5, 100 mM NaCl, 0.5% Triton X-100, 1 mM PMSF,
and 5 mM MgCl
 
2
 
). Protein precipitates were washed two times in buffer B
supplemented with an additional 100 mM NaCl and once in buffer B mi-
nus the Triton X-100. Bound proteins were eluted by boiling in SDS sam-
ple buffer and subjected to Western blot analysis with the anti-PLC
 
g
 
1 or
anti-IQGAP antibody. Binding experiments between the GST fusion pro-
teins and purified PLC
 
g
 
1 from insect cell lysates (a gift from Fujio Sekiya
and Sue Goo Rhee, NIH) were performed in a similar manner.
 
b
 
-Hexosaminidase Secretion Assay
 
RBL-2H3 cells were plated in 48-well plates at a density of 2.5
 
 3 
 
10
 
5
 
 cells/
well overnight at 37
 
8
 
C and infected the following day. Infected cells were
washed twice with Tyrode’s buffer (135 mM NaCl, 5 mM KCl, 1.8 mM
CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 5.6 mM glucose, 1 mg/ml BSA, and 20 mM Hepes,
pH 7.4), and stimulated with 100 ng/ml DNP/BSA for 1 h at 37
 
8
 
C. The
 
b
 
-hexosaminidase content of samples was determined as previously de-
scribed (Pierini et al., 1996). In brief, 50 
 
m
 
l of sample supernatant were in-
cubated with 200 
 
m
 
l of 1 mM 
 
p
 
-nitrophenyl-
 
N
 
-acetyl-
 
b
 
-
 
D
 
-glucosaminide
(Sigma) in 0.05 M citrate buffer (pH 4.5) for 1 h at 37
 
8
 
C. After quenching
of the reaction with the addition of 500 
 
m
 
l of 0.05 M sodium carbonate and
0.05 M sodium bicarbonate, the 
 
b
 
-hexosaminidase release was determined
by comparing the OD
 
400
 
 measurements of the samples to the total amount
of enzyme in cells lysed by 0.5% Triton X-100. For assays in which antigen
stimulation was bypassed, cells were incubated in 20 nM PMA for 5 min,
and then stimulated with either 1 
 
m
 
M A23187 or 500 nM thapsigargin
(Calbiochem) for 1 h at 37
 
8
 
C.
 
Calcium Fluorescence
 
RBL-2H3 cells were plated in 100-mm plates at a density of 4
 
 3 
 
10
 
6
 
 cells/
plate overnight at 37
 
8
 
C and infected the following day. Infected cells were
harvested, washed twice, and resuspended in Tyrode’s buffer supple-
mented with 0.25 mM sulfinpyrazone at 1
 
 3 
 
10
 
6
 
 cells/ml, and then loaded
with 0.5 
 
m
 
M Indo-1/AM (Calbiochem) for 1 h with constant agitation at
37
 
8
 
C. Cells were then washed twice and resuspended in Tyrode’s buffer
and 0.25 mM sulfinpyrazone at 1
 
 3 
 
10
 
6
 
 cells/ml. 3-ml aliquots of cell sus-
pension were added to acrylic cuvettes maintained at 37
 
8
 
C and constantly
stirred during the course of the experiment. DNP/BSA was added at 100
ng/ml to initiate calcium signaling. For experiments that specifically evalu-
ate release of calcium from ER stores, 4 mM EGTA was added to cells be-
fore DNP/BSA stimulation. Indo-1 was excited at 330 nm and fluores-
cence emission was monitored at 400 nm with a Perkin-Elmer LS-5
fluorescence spectrophotometer.
 
IP
 
3
 
 Determination
 
The amount of IP
 
3
 
 in cells was determined using the [
 
3
 
H] radioreceptor as-
say kit (Dupont-NEN). RBL-2H3 cells were plated in 70 mm plates at a
density of 3
 
 3 
 
10
 
6
 
 cells/ plate overnight and infected the following day. In-
fected cells were washed twice with Tyrode’s buffer, stimulated for 5 min
with 100 ng/ml DNP/BSA, and lysed according to the manufacturer’s in-
structions. The aqueous phases of the IP
 
3
 
 samples were ultrafiltered
through a Centricon concentrator (Amicon) with a membrane cut-off of
10,000 mol wt to exclude proteoglycans that interfere with the assay (Choi
et al., 1993).
 
Immunofluorescence
 
RBL-2H3 cells were plated on glass coverslips in 6-well plates at a density
of 2 
 
3 
 
10
 
5
 
 cells/well overnight and infected the following day. Infected
 
cells were stimulated with 100 ng/ml DNP/BSA for 30 min, fixed in PBS/
3.7% formaldehyde for 8 min, and permeabilized in PBS/0.1% Triton
X-100 for 5 min. Incubations with primary and secondary antibody were
performed for one hour each in a dark, humid chamber at 25
 
8
 
C. IP
 
3
 
 recep-
tors were detected using a 1:100 dilution of rabbit anti-IP
 
3
 
 receptor anti-
body (Calbiochem) followed by a 1:200 dilution of anti-rabbit IgG conju-
gated to the Bodipy fluorophore (Molecular Probes). Cells were mounted
in non-fade medium (Kirkegaard and Perry) and photographed on a Zeiss
axioscope (Carl Zeiss, Inc.) with T-Max 400 film (Eastman Kodak
Co.,  Inc.).
 
Results
 
Expression of Functional Wild-Type and Mutant Forms 
of Cdc42 and Rac Using a Vaccinia Virus
Expression System
 
We have employed the vaccinia virus expression system
to introduce dominant-active and dominant-negative
mutants of Cdc42 and Rac, tagged with the myc epitope,
into RBL-2H3 cells. To investigate whether the virus-
expressed GTPases would exhibit the expected proper-
ties-dictated by the different mutations, in vitro binding
experiments were performed between lysates from in-
fected RBL-2H3 cells expressing the various mutants and
GST fused to the GTPase (p21)-binding domain (PBD) of
the p21-activated kinase, PAK3 (Bagrodia et al., 1995).
The PBD, or CRIB motif, for Cdc42/Rac interactive bind-
ing, is conserved in a number of different effector proteins
and mediates their interactions with Cdc42 and Rac in a
GTP-dependent manner.
Examination of the virus-expressed mutant protein
bound to GST-PBD by Western blotting using the anti-myc
antibody demonstrated that both of the dominant-active
mutants, Cdc42
 
V12
 
 and Rac
 
V12
 
, interacted with GST-PBD
(Fig. 1 b, lanes 4 and 9). In contrast, the two dominant-
negative mutants, Cdc42
 
N17
 
 and Rac
 
N17
 
, did not exhibit
any detectable binding to the fusion protein (Fig. 1 b, lanes
5 and 10), as was the case with lysates from uninfected
cells (Fig. 1 b, lanes 1 and 6) and cells infected with empty
vector (Fig. 1 b, lanes 2 and 7). The wild-type forms of
Cdc42 and Rac displayed relatively weaker binding, pre-
sumably reflecting a subpopulation of the wild-type
GTPases that had acquired an activated state (Fig 1 b,
lanes 3 and 8). Protein expression levels from infections
between the three forms of Cdc42 (Fig. 1 a, lanes 3–5) and
Rac (Fig. 1 a, lanes 8–10) were comparable, indicating that
uniform expression with different vaccinia viruses can be
achieved. These results indicate that the virus-expressed
forms of Cdc42 and Rac displayed the behavior predicted
by their respective mutations and can be used to function-
ally interfere with the endogenous GTPases in RBL-2H3
cells.
 
Antigen-stimulated Degranulation Is Enhanced by 
Dominant-Active Cdc42 and Rac and Inhibited by 
Dominant-Negative Cdc42 and Rac
 
The effects of expressing dominant-active or dominant-
negative mutants of Cdc42 and Rac on degranulation were
examined by measuring the secretion efficiency of infected
RBL-2H3 cells after antigen stimulation. Since any pertur-
bation in the degranulation process will require sufficient
expression of the recombinant protein in order to compete 
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with endogenous wild-type protein for target binding, the
relative levels of the virus-expressed and endogenous pro-
teins in infected RBL-2H3 cells were determined. The re-
combinant proteins migrated with a slower mobility on
Western blots probed with anti-Cdc42 and anti-Rac anti-
bodies, compared with endogenous protein, due to the
presence of the myc epitope (Fig. 2 a, lanes 3–5 and 7–9)
and were absent in uninfected cells (Fig. 2 a, lane 1) and
cells infected with empty vector (Fig. 2 a, lanes 2 and 6).
Comparison of the protein levels between the two differ-
ent forms revealed that approximately 
 
$
 
50% of the total
Cdc42 and Rac in the cell was derived from the virus-
expressed source.
Secretion assays were performed in infected RBL-2H3
cells by measuring the relative amounts of 
 
b
 
-hexosamini-
dase, a secretory granule enzyme that is released into the
extracellular media upon antigen stimulation with DNP/
BSA. The infection process itself produced a modest in-
hibitory effect on degranulation, as evidenced by cells in-
fected with empty vector exhibiting 
 
z
 
26% secretion, a
one-quarterfold decrease compared with the 
 
z
 
35% secre-
tion observed with uninfected cells (Fig. 2 b, 
 
1
 
DNP/BSA).
Strikingly, infection with the dominant-active mutants,
Cdc42
 
V12
 
 and Rac
 
V12
 
, enhanced the antigen-stimulated se-
cretion to 
 
z
 
46% and 
 
z
 
53%, respectively, thus causing
roughly a twofold increase compared with the release ex-
hibited by cells infected with empty vector. In contrast, ex-
pression of the dominant-negative mutants, Cdc42
 
N17
 
 and
RacN17, produced an inhibitory effect, reducing the levels
of secretion to one-half of that of the empty vector control
(i.e., values of z13% and z15%, respectively). The effects
exhibited by the Cdc42 and Rac mutants confirmed that
the levels of recombinant protein were sufficient to in-
terfere with the activity of the endogenous wild-type pro-
tein. Overall, the ability of dominant-active Cdc42V12 and
RacV12 to enhance antigen-stimulated secretion, together
with the inhibitory effects caused by the corresponding
dominant-negative mutants, Cdc42N17 and RacN17, strongly
implicate Cdc42 and Rac in the signal transduction path-
way leading to exocytosis.
Infection with wild-type Cdc42 and Rac resulted in lev-
els of secretion comparable to those obtained with an
empty vector control, albeit at slightly inhibited levels of
z18% and z23%, respectively. The wild-type GTPases
might have been predicted to either slightly stimulate se-
cretion, since a fraction of each GTPase is present in an ac-
tivated state (Fig. 1 b, lanes 4 and 9), or not affect secre-
tion levels at all compared with the empty vector control.
Instead, we have consistently observed that the wild-type
Cdc42 or Rac has a slight inhibitory effect, which suggests
that the wild-type GTPases enter into nonproductive bind-
ing interactions with other proteins that function down-
stream in this signaling pathway leading to degranulation.
Figure 1. Wild-type and mutant forms of Cdc42 and Rac ex-
pressed using vaccinia virus are functionally active. (a) RBL-2H3
cells were infected with vaccinia virus containing empty vector
(lanes 2 and 7), or a vector expressing Cdc42 (lane 3), Cdc42V12
(lane 4), Cdc42N17 (lane 5), Rac (lane 8), RacV12 (lane 9), or
RacN17 (lane 10) for 6 h at 378C, or were uninfected (lanes 1 and
6). Proteins were solubilized, resolved by SDS-PAGE, and the
recombinant proteins were detected by Western blotting using
anti-myc antibody. The additional protein bands present in the
lanes containing lysates of the different forms of Rac are nonspe-
cific (lanes 8–10), since they also appear in the uninfected and
empty vector lanes (lanes 6 and 7). (b) Uninfected and infected
RBL-2H3 whole cell lysates were incubated with immobilized
GST-PBD for 1 h at 48C. Bound proteins were washed and sub-
jected to Western analysis using the anti-myc antibody. Figure 2. Dominant-active Cdc42 and Rac enhance secretion,
whereas dominant-negative Cdc42 and Rac inhibit secretion. (a)
RBL-2H3 cells were infected with vaccinia virus containing
empty vector (lanes 2 and 6), or a vector expressing Cdc42 (lane
3), Cdc42V12 (lane 4), Cdc42N17 (lane 5), Rac (lane 7), RacV12
(lane 8), or RacN17 (lane 9) for 6 h at 378C, or were uninfected
(lane 1). Proteins were solubilized and resolved by SDS-PAGE.
Cdc42 and Rac were detected by Western blotting using either
anti-Cdc42 or anti-Rac antibody, respectively. Virus-expressed
proteins migrate at a slightly higher molecular mass compared
with the endogenous protein due to the presence of the myc
epitope. (b) b-Hexosaminidase secretion was measured in RBL-
2H3 cells infected with the different forms of Cdc42 and Rac
upon stimulation with 100 ng/ml DNP/BSA for 1 h at 378C and
under nonstimulated conditions. Degranulation is given as the
percent of total cellular b-hexosaminidase released, as measured
by treatment of RBL-2H3 cells in parallel with 0.5% Triton
X-100. Error bars represent the standard deviation of four inde-
pendent experiments. The paired t test was used to evaluate the
statistical significance between cells infected with empty vector
and Cdc42 (0.0264), empty vector and Cdc42N17 (0.0023), empty
vector and RacN17 (0.0191), Cdc42 and Cdc42N17 (0.0437), and
Rac and RacN17 (0.0424). A score of #0.05 denotes statistical sig-
nificance. The comparison between cells infected with empty vec-
tor and Rac was not statistically significant.Hong-Geller and Cerione Cdc42 and Rac Activate IP3/Calcium Signaling 485
One possibility is that the binding of GDP-bound Cdc42
and/or GDP-bound Rac to a target/effector occurs with a
measurable affinity, perhaps not significantly different
from that for the GTP-bound forms of these proteins, but
that the GDP-bound Cdc42/Rac interaction does not acti-
vate the target/effector. In such a case, the over-expression
of wild-type Cdc42 or Rac would competitively inhibit the
binding of the activated GTP-binding protein to the target
and yield an inhibitory effect.
Cells containing the empty vector or expressing the
wild-type and mutant forms of Cdc42 and Rac exhibited
similar levels of basal secretion (#5%) in the absence of
antigen treatment (Fig. 2 b, 2DNP/BSA). It is significant
to note that RBL-2H3 cells expressing the dominant-
active mutants, Cdc42V12 and RacV12, cannot bypass the
requirement for DNP/BSA to effect degranulation. Thus,
antigen binding may generate multiple signals in order to
trigger degranulation, at least one of which involves a
pathway that is not dependent on the activation of Cdc42
or Rac.
Cdc42 and Rac Function Upstream of the Calcium 
Influx Step and PKC Activation in
Signaling Degranulation
To locate the step that Cdc42 and Rac may be modulating
in the antigen stimulation pathway, infected cells were in-
duced to degranulate by treatment with a combination of
the calcium ionophore A23187 and phorbol 12-myristate
13-acetate (PMA). These agents synergistically act to by-
pass the requirement for antigen by directly initiating cal-
cium influx into the cytoplasm, and by activating PKC, re-
spectively (Katakami et al., 1984; Sagi-Eisenberg et al.,
1985). Under these conditions, the continued maintenance
of a secretion defect in cells expressing the dominant-neg-
ative mutants would indicate that the inhibition imparted
by Cdc42N17 and RacN17 occurs downstream of calcium in-
flux and PKC activation, whereas the ability to restore se-
cretion would indicate that dominant-negative Cdc42 or
Rac intervene at an upstream step.
Treatment of control cells with A23187 and PMA acti-
vated degranulation more strongly than DNP/BSA, in-
creasing the relative amount of b-hexosaminidase released
from z39% to z59% in uninfected cells (Fig. 3). In cells
infected with empty vector, degranulation was elevated
from  z28% in antigen-stimulated cells to z68% in
A23187/PMA-treated cells, thus demonstrating that the
slight decrease in secretion caused by vaccinia virus infec-
tion could be bypassed by treatment with A23187 and
PMA. Secretion was substantially less inhibited in cells in-
fected with either Cdc42N17 or RacN17 upon stimulation
with A23187 and PMA, with percent degranulation in-
creased from z6% and z16% in antigen-stimulated cells
to z45% and z46% in A23187/PMA-treated cells, respec-
tively. These levels of secretion were similar to those ex-
hibited by cells expressing the dominant-active Cdc42V12
and RacV12 mutants upon A23187 and PMA treatment.
The more modest inhibition that had been observed upon
expression of wild-type Cdc42 or Rac was also relieved,
with percent degranulation increased from z10% and
z23% in antigen-stimulated cells to z48% and z45% in
A23187/PMA-treated cells, respectively. Both A23187 and
PMA were required to achieve substantial rescue from the
inhibition. Stimulation with the ionophore alone restored
secretion to only half that observed with both treatments
in cells infected with the dominant-negative mutants,
whereas PMA by itself did not activate degranulation
above basal levels (data not shown).
It should be noted that we have consistently found that
treatment of cells expressing any form of Cdc42 or Rac
with ionophore plus PMA yields a final level of secretion
slightly below the levels measured in control cells (vector
alone or uninfected). At the present time, we do not know
the explanation for the slight dampening of the secretory
response that is caused by expressing either of these GTP-
ases. However, the fact that it is independent of their state
of activation suggests that the dampening effect may re-
flect a perturbation of the GTP-binding/GTPase cycle of
Cdc42 or Rac that occurs as an outcome of the general
overexpression of any of these GTPases.
An alternative strategy to activating calcium influx with
an ionophore is to treat cells with thapsigargin, a sesqui-
terpene lactone inhibitor of the ER Ca21-ATPase pump,
which normally maintains an intracellular calcium gradi-
ent by transporting free calcium from the cytoplasm back
into the ER lumen (Lytton et al., 1991). Thus, blocking
the function of the pump with thapsigargin effectively
increases the cytoplasmic levels of free calcium. Using
thapsigargin and PMA to stimulate degranulation, cells
infected with Cdc42N17 and RacN17 also exhibited elevated
levels of secretion, such that the percent degranulation
was comparable to cells infected with empty vector (data
not shown). The considerable stimulation of secretion
in cells expressing the dominant-negative and wild-type
Cdc42/Rac proteins implies that the combined effects of
calcium mobilization and PKC activation are able to
bypass the defect, thereby placing Cdc42 and/or Rac
Figure 3. Treatment with the calcium ionophore A23187 and the
PKC activator PMA rescues the secretion defect exhibited by an-
tigen-stimulated cells expressing dominant-negative Cdc42 and
Rac. RBL-2H3 cells were infected with vaccinia virus containing
empty vector, the different forms of Cdc42 and Rac, or unin-
fected, for 6 h at 378C. Cells were then stimulated with either 20 nM
PMA for 5 min followed by 1 mM A23187 for 1 h or 100 ng/ml
DNP/BSA for 1 h. Degranulation is given as the percent of total
cellular b-hexosaminidase released, as measured by treatment of
RBL-2H3 cells in parallel with 0.5% Triton X-100. Error bars
represent the standard deviation of four independent experi-
ments.The Journal of Cell Biology, Volume 148, 2000 486
upstream of these two events in the antigen signaling
pathway.
Cdc42 and Rac Regulate the Intracellular Calcium 
Response after Antigen Stimulation
In light of our finding that direct mobilization of calcium
into the cell can synergize with PKC activation to bypass
the inhibitory effects on degranulation caused by the dom-
inant-negative mutants, we examined the possibility that
Cdc42 and Rac may regulate the calcium influx pathway.
This could occur either by modulating the release of cal-
cium from ER stores or by directly activating plasma
membrane calcium channels. The calcium responses of
RBL-2H3 cells infected with the Cdc42 or Rac mutants
were compared with those of cells infected with empty
vector, in order to control for variations in cell number
and loading efficiency of the fluorescent dye Indo-1. Upon
antigen stimulation (Fig. 4, unfilled arrows), cells infected
with either Cdc42V12 or RacV12 exhibited an enhancement
of both phases of the calcium response, namely the initial,
rapid peak contributed by release from ER stores and the
influx pathway, and the more sustained plateau derived
primarily from influx (Fig. 4, g and i). Expression of either
dominant-negative mutants Cdc42N17 or RacN17, produced
the opposite effect, dampening the two phases of calcium
signaling (Fig. 4, h and j). The calcium response of cells in-
fected with empty vector was slightly inhibited, but did not
significantly differ from that of uninfected cells compared
with the effects generated by the Cdc42 and Rac mutants
(Fig. 4 a). Surprisingly, calcium signaling in cells express-
ing wild-type Cdc42 and Rac was very similar to that of
cells expressing the empty vector (Fig. 4, b and c). We had
expected the calcium response in the cells expressing the
wild-type GTPases to be less robust compared with that of
the vector control, consistent with our observation that ex-
pression of wild-type Cdc42 and Rac produced a small in-
hibition of antigen-stimulated secretion. The absence of an
effect on calcium signaling suggested the possibility that
the inhibitory effects produced by the wild-type GTPases
during antigen-stimulated secretion may be manifested
subsequent to calcium signaling. Rho GTPases have previ-
ously been suggested to play a role in the latter stages of
degranulation (Norman et al., 1996).
To specifically evaluate release of calcium from intracel-
lular stores, fluorescence assays performed in the presence
of EGTA, to chelate total extracellular calcium, were car-
ried out in parallel with experiments that contained free
calcium in the medium. The release of calcium from ER
stores has been implicated in directly activating the cal-
cium influx pathway (Hoth and Penner, 1992). Thus, an al-
teration in the amount of calcium exiting the ER may pro-
vide an explanation for the stimulation in the calcium
response observed with Cdc42V12 and RacV12, as well as
the inhibition obtained with Cdc42N17 and RacN17. Addi-
tion of EGTA decreased calcium fluorescence to a lower
resting level, presumably due to a small amount of extra-
cellular Indo-1 releasing its bound calcium (Fig. 4, d–f and
k–n, filled arrows). Subsequent antigen stimulation (Fig. 4,
d–f and k–n, unfilled arrows) triggered a sharp peak that
quickly returned close to the starting baseline fluores-
cence, confirming that the sustained plateau phase of the
calcium response seen in the absence of EGTA represents
the influx of extracellular calcium. Expression of the dom-
inant-active mutants, Cdc42V12 and RacV12, elevated the
peak of the calcium response compared with infection
with empty vector (Fig. 4, k and m). In contrast, infection
of cells with either Cdc42N17 or RacN17 led to a reduced
amplitude in calcium signaling (Fig. 4, l and n). Although
Figure 4. Dominant-active Cdc42 and Rac enhance calcium sig-
naling, while dominant-negative Cdc42 and Rac dampen calcium
signaling. The calcium responses of uninfected RBL-2H3 cells (a
and d), cells infected with vaccinia virus expressing wild-type
Cdc42 (b and e), wild-type Rac (c and f), Cdc42V12 (g and k),
Cdc42N17 (h and l), RacV12 (i and m), and RacN17 (j and n), were
compared with those of cells containing empty
vector. Cells were infected for 6 h at 378C
and loaded with Indo-1. Overall calcium re-
sponses were measured in a fluorescence
spectrophotometer in response to stimula-
tion with 100 ng/ml DNP/BSA (a–c and g–j,
unfilled arrows). To specifically measure the
release of calcium from ER stores (d–f and
k–n), loaded cells were treated with 4 mM
EDTA (filled arrows) and then stimulated
with 100 ng/ml DNP/BSA (unfilled arrows).
For each form of Cdc42 and Rac, measure-
ments of the calcium responses in the ab-
sence and presence of EGTA were per-
formed concurrently. Traces shown are
representative of three independent experi-
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expression of RacN17 generally produced a more pro-
nounced decrease in the release of calcium from intracel-
lular stores compared with Cdc42N17, the calcium re-
sponses in the presence of extracellular calcium are very
comparable. Since expression of the two dominant-nega-
tive GTPases inhibited overall calcium signaling to a very
similar extent, it may be that there is a threshold level of
calcium release from the ER, below which an inhibited
calcium signal is produced. Finally, the release of calcium
from ER stores in uninfected cells or cells expressing wild-
type Cdc42 and Rac did not significantly differ from the
empty vector control (Fig. 4, d–f)
The opposing effects produced by the dominant-active
and dominant-negative mutants indicate that Cdc42 and
Rac are able to directly modulate calcium signaling in re-
sponse to antigen stimulation. The finding that these op-
posing effects are also maintained in the presence of
EGTA strongly suggests that Cdc42 and Rac act upstream
of the release of calcium from the ER lumen rather than
directly on plasma membrane calcium channels. Altering
the ability of calcium to be released from stores would
subsequently influence the extent of calcium influx from
the extracellular medium.
Cellular IP3 Levels Are Enhanced in Cells Expressing 
Dominant-Active Cdc42V12 or RacV12 upon
Antigen Stimulation
We next investigated the step immediately before the re-
lease of calcium from the ER stores, that is, production of
the second messenger IP3. IP3, generated by the PLCg-
mediated cleavage of PIP2-4,5 in response to antigen stim-
ulation, binds to the IP3 receptor, a ligand-gated calcium
channel in the ER membrane. This activates channel
opening and calcium efflux into the cytoplasm (Ferris et
al., 1989; Mignery and Sudhof, 1990). The addition of
DNP/BSA to uninfected cells and to cells infected with
empty vector increased IP3 production by approximately
twofold compared with nonstimulated cells (Fig. 5). The
dominant-active mutants Cdc42V12 and RacV12 further en-
hanced the antigen-promoted IP3 production, such that
the stimulation was approximately threefold relative to
nonstimulated cells. Wild-type Cdc42 or Rac displayed a
modest (z1.5-fold) inhibition in antigen-stimulated IP3
production, while expression of the dominant-negative
mutants Cdc42N17 and RacN17 prevented any significant in-
crease in IP3 levels upon antigen stimulation, compared
with that of nonstimulated cells. We suspect that the levels
of antigen-stimulated IP3 production in cells expressing
dominant-negative Cdc42 or Rac are reduced relative to
cells expressing wild-type protein and in fact, this appears
to be the trend in any given experiment. However, when
averaging the experiments, the deviations are sufficiently
large to make it difficult to detect these differences and to
make a definitive conclusion.
The exact mechanism by which release of calcium from
the ER stores elicits calcium influx from the extracellu-
lar medium remains poorly understood. However, the en-
hancement in IP3 levels is consistent with the ob-
served  stimulation of the calcium response in cells
expressing dominant-active Cdc42V12 or RacV12, support-
ing our model that Cdc42 and Rac act upstream of IP3 pro-
duction to regulate calcium signaling and ultimately, de-
granulation.
Immunolocalization of the IP3 Receptor to Aggregates 
in the Cell Body Is Enhanced by Dominant-Active and 
Inhibited by Dominant-Negative Cdc42 or Rac
The IP3 receptor has been demonstrated by immunolocal-
ization studies to redistribute from a diffuse staining pat-
tern to large, distinct aggregates after antigen stimulation
in RBL-2H3 cells (Wilson et al., 1998). The functional sig-
nificance of the IP3 receptor clustering is unclear, although
models in which aggregation modulates channel opening
or IP3 receptor interaction with resident ER calcium-bind-
ing proteins have been proposed. Formation of these clus-
ters is highly dependent on elevated levels of intracellular
calcium, since treatment of cells with thapsigargin or the
ionophore ionomycin also produced cluster formation. We
have used this immunofluorescence assay to determine
whether the Cdc42 and Rac mutants and their concomi-
tant effects on IP3 production and calcium signaling could
also influence IP3 receptor clustering.
Upon antigen stimulation, permeabilized RBL-2H3
cells incubated with anti-IP3 receptor antibody displayed
an average of 4.5 small brightly labeled aggregates per cell
that localized to the periphery of the dense cell body (Fig.
6 b, see arrows and Table I), whereas nonstimulated cells
exhibited an extremely low level of cluster formation (Fig.
6 a and Table I). It seems likely that the cellular structure
outlined by the ring of aggregates represents the nuclear
envelope and the contiguous ER membranes, the primary
location of the IP3 receptor (Ross et al., 1989). This stain-
ing pattern differs from an earlier study in which the ag-
gregates were more evenly distributed in the cytoplasm
(Wilson et al., 1998). However, the discrepancy may be ex-
Figure 5. Dominant-active Cdc42 and Rac enhance IP3 levels in
the cell. RBL-2H3 cells were infected with vaccinia virus contain-
ing empty vector, a vector expressing different forms of Cdc42
and Rac, or uninfected, for 6 h at 378C. The IP3 levels in the cells
were determined according to the procedure described in Materi-
als and Methods for both nonstimulated cells and cells stimulated
with 100 ng/ml DNP/BSA for 5 min. Error bars represent the
standard deviation of four independent experiments. The stan-
dard deviations for unstimulated cells infected with empty vector
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plained by the different sources of IP3 receptor antibody
used in both analyses.
Antigen stimulation also produced a dramatic increase
in cell spreading, so that the flattened membrane exten-
sions (Fig. 6 b, see arrowheads) are clearly delineated
from the more central cell body (Fig. 6, compare a with b;
Pfeiffer et al., 1985). This morphological change was not as
pronounced in stimulated cells that underwent viral infec-
tion, presumably because the infection process itself in-
duces a rounding-up effect on cells (Elroy-Stein and Moss,
1991). Thus, stimulated cells infected with the different
forms of Cdc42 and Rac did not exhibit as flattened an ap-
pearance as stimulated, uninfected cells (Fig. 6, compare b
with c–i).
Expression of dominant-active Cdc42V12 and RacV12 in-
duced a similar ring-like staining pattern of IP3 receptor
upon antigen addition, displaying an average of 5.12 and
5.60 IP3 receptor clusters per cell, respectively (Fig. 6, e
and h, see arrows and Table I). Nonstimulated cells that
were infected with the dominant-active mutants did not
exhibit this clustering phenotype, indicating that virus in-
fection itself did not elicit a redistribution of the IP3 recep-
tor (data not shown). Brightly labeled clusters were also
visible in cells infected with empty vector (3.74 clusters/
cell), wild-type Cdc42 (3.22 clusters/cell), and wild-type
Rac (3.04 clusters/cell), although to a lesser extent than
seen for Cdc42V12 or RacV12 (Fig. 6, c, d, and g and Table
Figure 6. Dominant-negative Cdc42 and Rac inhibit aggregation of the IP3 receptor. RBL-2H3 cells were infected with vaccinia virus
containing (c) empty vector, a vector expressing (d) Cdc42, (e) Cdc42V12, (f) Cdc42N17, (g) Rac, (h) RacV12, or (i) RacN17 for 6 h at 378C, or
were (a and b) uninfected. The cellular distribution of IP3 receptor in cells stimulated with 100 ng/ml DNP/BSA for 30 min (b–i) and in
nonstimulated cells (a) was examined by indirect immunofluorescence using rabbit anti-IP3 receptor antibody and a Bodipy-conjugated
anti-rabbit secondary antibody. Stimulation of uninfected cells with antigen (b) induces cell spreading (arrowheads) and IP3 receptor
aggregate formation in a ring-like structure (arrows). IP3 receptor aggregate formation is also indicated in cells infected with Cdc42V12
and RacV12 (e and h, arrows).
Table I. Distribution of IP3 Receptor Clusters in RBL-2H3 
Cells Infected with Different Forms of Cdc42 and Rac
Virus DNP/BSA Number of clusters/cell
Uninfected 2 0.04
Uninfected 1 4.50
Vector 1 3.74
Cdc42 1 3.22
Cdc42V12 1 5.12
Cdc42N17 1 0.18
Rac 1 3.04
RacV12 1 5.60
RacN17 1 0.12
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I). However, cluster formation was nearly eliminated in
cells expressing the dominant-negative mutants, Cdc42N17
and RacN17, except for the occasional single aggregate
(Fig. 6, f and i and Table I).
Given the requirement for the calcium influx pathway in
IP3 receptor redistribution, the observed increase in aggre-
gate formation is consistent with the stimulated IP3 pro-
duction and subsequent enhanced calcium signaling exhib-
ited by cells infected with either Cdc42V12 or RacV12.
Interestingly, RBL-2H3 cells infected with either Cdc42N17
or RacN17 displayed a striking decrease in aggregate for-
mation, despite the fact that the calcium responses in these
cells were inhibited, but not completely abolished, com-
pared with infection with empty vector. This suggests that
a threshold level exists for cytoplasmic calcium above
which IP3 receptors undergo aggregation. The IP3 receptor
contains several calcium-binding sites through which cal-
cium may mediate its effects on IP3 receptor redistribution
(Sienaert et al., 1997).
Cdc42 Interacts with PLCg In Vitro in a
GTP-dependent Manner
The combined effects on calcium signaling, IP3 produc-
tion, and IP3 receptor aggregation strongly argue that
Cdc42 and/or Rac function upstream of IP3 formation.
Additionally, the observation that PMA synergizes with
A23187 to strongly stimulate degranulation in cells in-
fected with the dominant-negative mutants suggests that
Cdc42 and/or Rac also act upstream of diacylglycerol for-
mation, which normally activates PKC. In an effort to be-
gin to identify the target that Cdc42 and Rac may be mod-
ulating in the IP3/calcium pathway, we focused on PLCg,
the enzyme responsible for cleaving PIP2-4,5 into IP3 and
diacylglycerol. A recent study had demonstrated that both
Cdc42 and Rac can stimulate the activity of phospholipase
Cb2 in a purified protein system (Illenberger et al., 1998),
thus providing a precedent for small G proteins to interact
with members of the PLC family.
Binding studies were performed by incubating lysates
from nonstimulated (Fig. 7 a) and stimulated (Fig. 7 b)
RBL-2H3 cells with GST fusions to wild-type and mutant
forms of Cdc42. The dominant-active Cdc42L61, and to a
lesser extent, wild-type Cdc42, interacted with a protein
that migrated with the expected mobility (z145 kD) of
PLCg1 and was recognized by an anti-PLCg1 antibody on
Western blots for both nonstimulated (Fig. 7 a, upper
panel, lanes 3 and 4) and stimulated (Fig. 7 b, upper panel,
lanes 3 and 4) lysates. This protein did not bind to the
dominant-negative mutant Cdc42N17 (Fig. 7, a and b, upper
panels, lane 5) nor to GST alone (Fig. 7, a and b, upper
panels, lane 1). Probing these Western blots with antibody
to IQGAP, a known target/effector protein for Cdc42
(Kuroda et al., 1996; McCallum et al., 1996), exhibited a
very similar binding profile (Fig. 7, a and b, lower panels).
Thus, these results indicate that PLCg1 may in fact serve
as a target for activated Cdc42 and could represent a focal
point from which Cdc42 influences calcium signaling in
RBL-2H3 cells.
The observation that activated Cdc42 binds to PLCg1
from unstimulated lysates suggests that the phosphoryla-
tion state of PLCg1 is unimportant in the binding interac-
tion. It is important to note that these in vitro binding re-
sults may not necessarily reflect the in vivo spatial and
timing events that most likely regulate the binding of
PLCg1 and Cdc42 at the plasma membrane. Although ac-
tivated Cdc42 appears to bind equally well to PLCg1 from
either stimulated or unstimulated RBL-2H3 lysates in
vitro, the Cdc42/PLCg1 interaction may still be carefully
regulated by antigen stimulation in the cell, which signals
translocation of PLCg1 to the plasma membrane for acti-
vation via phosphorylation.
We have not found that activated Cdc42 stimulates
PLCg1 activity, upon mixing the two purified recombinant
proteins. However, experiments using purified PLCg1
from insect cells suggest that activated Cdc42 binds prefer-
entially to a form of PLCg1 that migrates with a slightly
faster mobility compared with the majority of the PLCg1
protein (data not shown). Interestingly, this more mobile
form of PLCg1 from insect cells comigrated with the pro-
tein from RBL-2H3 lysates that interacted with activated
GST-Cdc42 and was recognized by the anti-PLCg1 anti-
body. At present, we do not know if this altered mobility
reflects a specific posttranslational modification of PLCg1
that is necessary for efficient binding to Cdc42, but the in-
ability to assay a population of fully modified PLCg1 may
explain the lack of a Cdc42-mediated effect in activity as-
says.
Introduction of the Y40 Effector Domain Mutation into 
Cdc42V12 Decreases the Enhanced Calcium Signaling 
Exhibited by Cells Infected with Cdc42V12 Alone
The GTPase family members contain a short effector
binding domain from residues 32–40, termed the Switch I
region, that mediates binding to a variety of target pro-
teins in a GTP-dependent manner. To obtain further sup-
port that Cdc42 plays a role in degranulation through the
signaling of downstream effector targets, we have con-
structed a virus expressing the Cdc42V12,Y40 double mutant
to determine whether disruption of Cdc42 binding to ef-
fector proteins would affect the enhanced calcium signal-
ing and secretory response in cells infected with Cdc42V12
Figure 7. Activated Cdc42 interacts with PLCg1 in vitro. Lysates
from (a) unstimulated RBL-2H3 cells and (b) cells stimulated
with 100 ng/ml DNP/BSA for 5 min were incubated with immobi-
lized GST (lane 2), GST-Cdc42 (lane 3), GST-Cdc42L61 (lane 4),
and GST-Cc42N17 (lane 5) for 1 h at 48C. Lane 1 contains whole
cell lysate used in the binding reactions. Bound proteins were
washed, resolved by SDS-PAGE, and analyzed by Western blots
using either anti-PLCg1 antibody (upper panel) or anti-IQGAP
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alone. The Y40 mutation has been demonstrated to pre-
vent Cdc42 interaction with targets containing the CRIB
domain, which leads to defective signaling in the JNK
transcriptional activation pathway (Lamarche et al., 1996).
The virus-expressed Cdc42V12,Y40 did not bind to the GST-
PBD fusion protein (Fig. 8, lane 5), indicating that intro-
duction of the Y40 mutation disrupted the ability of
Cdc42V12 to interact with GST-PBD (Fig. 8, lane 3). Upon
antigen stimulation (Fig. 8 b, unfilled arrow), cells express-
ing Cdc42V12,Y40 exhibited a reduction in both the initial
peak and sustained plateau phases of the calcium re-
sponse, compared with cells expressing Cdc42V12 alone.
The Y40 mutation did not completely inhibit the stim-
ulatory effects of the dominant-active V12 mutation,
since cells expressing Cdc42V12,Y40 still displayed an en-
hancement of calcium signaling over cells infected with
empty  vector. Furthermore, expression of Cdc42V12,Y40
also dampened the release of calcium from ER stores
compared with cells expressing Cdc42V12, suggesting that
the Y40 mutation most likely impaired a step before the
initiation of calcium signaling (Fig. 8 c). Finally, expression
of Cdc42V12,Y40 exhibited z32% secretion, compared with
z40% in cells expressing Cdc42V12 and z25% in cells ex-
pressing empty vector (data not shown). Taken together,
the inhibition of calcium signaling and secretion produced
by the Cdc42V12,Y40 double mutant are consistent with a
defect in IP3 production and further supports our hypothe-
sis that Cdc42/Rac interaction with downstream effectors
is a key step in the pathway leading to calcium mobiliza-
tion and degranulation.
Discussion
The Rho family of small GTP-binding proteins plays criti-
cal regulatory roles in a variety of cellular processes, in-
cluding cytoskeletal organization, cell motility, transcrip-
tional signaling, and cell cycle progression (for review, see
Hall, 1998). In this study, we have implicated Cdc42 and/or
Rac in a novel biological function to signal the degranula-
tion of secretory vesicles in RBL-2H3 cells. By expressing
dominant-active and dominant-negative mutants using
vaccinia virus, we have demonstrated that Cdc42 and Rac
act early in this signaling pathway by activating IP3 pro-
duction and the subsequent rise in intracellular calcium
upon antigen stimulation. Viral expression vectors for a
third member of the Rho family, RhoA, were also con-
structed. However, infection of HeLa cells with dominant-
active RhoA induced dramatic cellular events, such as a
misshapen cell morphology and abnormal actin localiza-
tion. Since these phenotypes were indicative of aberrant
cellular behavior and physiology, we discontinued further
study of RhoA in the context of degranulation in RBL-
2H3 cells.
A role for the small GTPases, Cdc42, Rac, and Rho, in
exocytosis had been proposed based on earlier work in
which the addition of activated, recombinant GTPases en-
hanced degranulation in permeabilized cells (Norman et
al., 1994; Price et al., 1995; Brown et al., 1998). The major-
ity of these studies had made the presumption that the
GTPases were stimulating degranulation by primarily in-
ducing the actin cytoskeletal rearrangements that nor-
mally accompany secretion. Filamentous actin depoly-
merizes in the cortical region underneath the plasma
membrane and repolymerizes in the cell interior upon an-
tigen stimulation (Koffer et al., 1990; Norman et al., 1994).
This redistribution is thought to be required for relieving
steric hindrance at the cell periphery, allowing secretory
granules to gain access to the plasma membrane for fusion
and release of their contents (Lelkes et al., 1986). In addi-
tion, recombinant Rac and Rho have been shown to en-
hance secretion in permeabilized mast cells that had been
stimulated with GTPgS in the presence of high calcium,
suggesting that the Rho GTPases also perform as yet un-
known functions in later stages of the signaling pathway
following the calcium influx step (Norman et al., 1996).
Our observation that expression of wild-type Cdc42 or
Rac did not appear to inhibit calcium signaling suggested
the possibility that the inhibitory effects produced during
antigen-stimulated secretion may be manifested after the
activation of the calcium influx pathway. Although it re-
mains unclear why wild-type Cdc42 or Rac produces an
inhibitory effect on secretion, we speculate that over-
expression of these proteins, through competition with the
activated forms of GTP-binding protein, apparently can
form a nonproductive complex with a target-effector that
is important for secretion and thereby inhibits this signaling
response. Finally, our demonstration that Cdc42 and Rac
stimulate IP3 formation and calcium signaling upon anti-
gen stimulation leads us to favor a model in which the GTP-
ases play a role in at least three processes that are able to
influence degranulation: (a) stimulation of calcium signal-
Figure 8. Cells infected with the effector domain mutant
Cdc42V12,Y40 exhibit impaired calcium signaling compared with
cells infected with Cdc42V12. (a) Lysates from RBL-2H3 cells in-
fected with vaccinia virus containing empty vector (lane 1), or a
vector expressing Cdc42 (lane 2), Cdc42V12 (lane 3), Cdc42N17
(lane 4), and Cdc42V12,Y40 (lane 5) were treated as described in
the legend to Fig. 1, a and b. (b) The calcium responses of RBL-
2H3 cells infected with Cdc42V12,Y40 were compared with those of
Cdc42V12 and empty vector upon antigen stimulation (unfilled ar-
rows) in the absence or presence (c) of 4 mM EGTA (filled ar-
row). Traces shown are representative of three independent ex-
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ing and PKC activation (Fig. 9, a and b), (b) actin cytoskel-
etal changes (Fig. 9 c), and (c) an unidentified function
subsequent to calcium influx (Fig. 9 d).
So far, we have not been able to detect Rho GTPase-
mediated effects on events upstream of IP3 production in
the signaling pathway. Antigen stimulation induces the ac-
tivation of many signaling proteins via tyrosine phos-
phorylation events in RBL-2H3 cells (Li et al., 1992). Ex-
pression of dominant-negative Cdc42 did not significantly
alter the pattern of enhanced phosphorylation in stimu-
lated RBL-2H3 cell lysates on Western blots probed with
anti-phosphotyrosine antibody (data not shown). In COS7
monkey kidney cells and NIH-3T3 mouse fibroblast cells
infected with dominant-negative Cdc42, immunoprecipi-
tated PLCg1 was phosphorylated to the same extent as
cells infected with empty vector, indicating that dominant-
negative Cdc42 did not interfere with events leading up to
the phosphorylation of PLCg1 in these cell types (data not
shown).
In addition, we do not think that it is likely that cyto-
skeletal changes induced by viral infection caused any dra-
matic effect to the signaling pathway leading to degranula-
tion since cells that were infected with empty vector still
exhibited a strong level of secretion in response to antigen
stimulation. However, cytoskeletal changes produced by
viral infection may be one of the factors that contributed
to the modest decrease in secretion efficiency upon infec-
tion with the vector control compared with uninfected
cells. We have attempted to look at the consequence of
vaccinia infection on FceRI-induced cytoskeletal reorgani-
zation by staining cells with phalloidin and performing im-
munofluorescence. Unfortunately, viral infection induced
a rounding up of the cells during the course of the infec-
tion, thus making it more difficult to distinguish the fine
structure of cytoskeletal elements.
We suspect that the observed changes in IP3 formation
and calcium signaling are not merely secondary pheno-
types induced by Cdc42 and Rac effects on actin remodel-
ing. Treatment of cells with the phorbol ester, PMA, in-
duced cytoskeletal changes similar to those resulting from
incubation with both PMA and the calcium ionophore
A23187. However, the combination of PMA and A23187
strongly stimulated degranulation, whereas PMA alone
did not, indicating that cytoskeletal rearrangement is in-
sufficient to induce the signaling pathway leading to secre-
tion (Ludowyke et al., 1994). In addition, our in vitro bind-
ing studies identifying an interaction between Cdc42 and
PLCg1 suggest that Cdc42 feeds directly into the IP3/cal-
cium signaling pathway.
PLCg hydrolyzes PIP2-4,5 to form the two second mes-
sengers, IP3, which binds to the IP3 receptor in the ER
membrane to release internal calcium stores, and 1,2-dia-
cylglycerol, which stimulates PKC activity. Thus, activa-
tion of PLCg is instrumental in initiating a signaling cas-
cade in a wide variety of cell types that responds to
receptor–ligand interactions at the cell surface. Three ma-
jor families of PLC have been identified: b, g, and d (for
review, see Rhee and Bae, 1997). PLCb and PLCg stimu-
lation are linked to receptors coupled to heterotrimeric G
proteins and tyrosine kinases, respectively, whereas a role
for PLCd activation by cell surface receptors remains un-
clear. PLCb2 has been characterized as a target for Cdc42
and Rac in a study describing the isolation of a complex
between Cdc42 and LyGDI, which was found to mediate
GTP-dependent activation of PLCb2 in vitro (Illenberger
et al., 1998). Rac, but not Rho, was also capable of stimu-
lating PLCb2 activity. This activation was further ob-
served in a system composed of purified recombinant pro-
teins, suggesting that the interaction between Cdc42/Rac
and PLCb2 was direct. Cdc42/Rac activation of PLCb2 ap-
peared to be very specific since the GTPases could not en-
hance the activity of PLCd1 or a second PLCb isoform,
PLCb1 (Illenberger et al., 1997).
We had originally focused on PLCg1 as a possible target
for the Rho GTPases in stimulating the IP3/calcium path-
way based on the work examining Cdc42/Rac-mediated
activation of PLCb2. We have established an in vitro inter-
action between purified, recombinant GST-Cdc42 and a
protein from RBL-2H3 cell lysates that closely matched
the expected molecular mass (z145 kD) of PLCg1 and
was recognized by a polyclonal antibody raised against
amino acids 1249–1262 at the COOH terminus of PLCg1,
but migrated slightly faster than the majority of the PLCg1
purified from insect cells. The purified PLCg1 contained a
component protein that both comigrated with the interact-
ing protein from RBL-2H3 cell lysates and bound to GST-
Cdc42 in a GTP-dependent manner. This suggests that it
may be a modified form of PLCg1 that binds most effec-
tively to activated Cdc42, and perhaps results in a special-
ized regulatory function that links Cdc42 to signaling
events that lead to secretion. We attempted to determine
whether the small increase in mobility observed for the
PLC-immunoreactive species that binds Cdc42 may have
Figure 9. Model for the roles that Cdc42 and Rac play in stimu-
lating exocytosis of secretory granules in RBL-2H3 cells. Upon
antigen stimulation, Cdc42 and/or Rac activate at least three pro-
cesses that are required for degranulation: (a and b) stimulation
of calcium signaling and PKC activation, (c) actin cytoskeletal re-
modeling, and (d) an as yet unidentified function subsequent to
calcium influx during the later stages of degranulation.The Journal of Cell Biology, Volume 148, 2000 492
been caused by hypophosphorylation of PLCg1. In both
quiescent NIH-3T3 cells and A431 human epidermoid
cells, PLCg1 in its basal state has been demonstrated to
contain phosphoserine (Meisenhelder et al., 1989). Thus, it
seemed possible that a percentage of the total purified, in-
sect cell-expressed PLCg1 may contain fewer phosphate
groups on serine residues, and thus account for the faster
mobility in protein gels. However, treatment of purified or
immunoprecipitated PLCg1 with potato acid phosphatase
to remove susceptible phosphate groups did not yield a
lower molecular mass protein (data not shown). There are
a number of other possibilities for Cdc42/PLCg1 interac-
tions that remain to be addressed. For example, it is possi-
ble that the association between activated Cdc42 and an
unmodified PLCg1 is transient, as thus far, we have been
unable to detect a stable in vivo complex between PLCg1
and Cdc42 using coimmunoprecipitation methods.
In addition to possibly regulating PLCg1 directly and re-
modeling the cytoskeletal architecture, the Rho GTPases
may also modulate the activities of other signaling mole-
cules that play a role in triggering degranulation. Some po-
tential candidates belong to the lipid kinase family, which
generates lipid products that perform key signaling tasks
after antigen stimulation. First, phosphoinositide 3-kinase
(PI3-K) phosphorylates PIP2-4,5 to form phosphatidylino-
sitol-3,4,5-trisphosphate (PIP3-3,4,5), which can induce
PLCg1 translocation to the plasma membrane via interac-
tions with its pleckstrin homology and SH2 domains (Bae
et al., 1998; Falasca et al., 1998). Since Cdc42 and Rac have
been shown to stimulate PI3-K activity in a GTP-depen-
dent manner (Zheng et al., 1994; Tolias et al., 1995), the
GTPases may be exerting their influence on PLCg1 indi-
rectly by stimulating PI3-K to generate higher levels of
PIP3-3,4,5. Furthermore, treatment of RBL-2H3 cells with
the PI3-K inhibitor, wortmannin, attenuated the secretory
response, suggesting that PI3-K activity is essential for de-
granulation to occur (Yano et al., 1993). Second, the com-
bined activities of phosphatidylinositol phosphate 4-kinase
(PIP4-K) and phosphoinositide 4,5-kinase (PI5-K) gener-
ate PIP2-4,5, the target lipid that is cleaved by PLCg1 (for
review, see Toker, 1998). Both Rac and Rho have been
implicated in activating these lipid kinases to increase pro-
duction of PIP2-4,5 (Chong et al., 1994; Hartwig et al.,
1995), which may subsequently upregulate the signaling
pathway leading to degranulation by providing more sub-
strate for PLCg1. Finally, sphingosine kinase activity has
been shown to mobilize calcium upon antigen stimulation
(Choi et al., 1996), suggesting that multiple signals may be
activated to elevate intracellular levels of calcium. The im-
plication of sphingosine lipids in mediating calcium signal-
ing identifies them as possible targets for regulation by the
Rho GTPases.
In summary, we now present findings that highlight an
important role for the Cdc42 and/or Rac GTPase in medi-
ating calcium changes that are critical for the exocytosis of
secretory granules. These regulatory events occur at a step
immediately upstream of calcium release from stores and
appear to impact on IP3 production and on the interplay
between this second messenger and the aggregation of its
ER receptor/calcium channels. The ability of activated
Cdc42 and/or Rac to bind PLCg1 may underlie a key step
in what is likely to be a complex regulation of calcium sig-
naling via antigen binding and the resultant activation of
Rho GTPases. Future efforts will be directed at better un-
derstanding the mechanistic basis by which Cdc42 and Rac
influence calcium changes and whether other aspects of
antigen-mediated secretion are also affected by these
GTPases.
We thank D. Holowka for helpful discussions throughout the course of
this work and for critically reading this manuscript. We also thank C. Few-
trell for the use of her fluorescence spectrophotometer, D. Holowka, B.
Baird, B. Moss, F. Sekiya, and S.G. Rhee for sharing reagents, and C.
Westmiller for secretarial assistance.
This work is supported by National Institutes of Health grant GM47458
to R.A. Cerione and an American Cancer Society post-doctoral fellow-
ship to E. Hong-Geller.
Submitted: 13 August 1999
Revised: 15 December 1999
Accepted: 21 December 1999
References
Aridor, M., G. Rajmilevich, M.A. Beaven, and R. Sagi-Eisenberg. 1993. Activa-
tion of exocytosis by the heterotrimeric G protein Gi3. Science. 262:1569–
1572.
Bae, Y.S., L.G. Cantley, C. Chen, S. Kim, K. Kwon, and S.G. Rhee. 1998. Acti-
vation of phospholipase C-g by phosphoinositol 3,4,5-trisphosphate. J. Biol.
Chem. 273:4465–4469.
Bagrodia, S., B. Derijard, R.J. Davis, and R.A. Cerione. 1995. Cdc42 and PAK-
mediated signaling leads to jun kinase and p38 mitogen-activated protein ki-
nase activation. J. Biol. Chem. 270:27995–27998.
Beaven, M.A., and R.A. Baumgartner. 1996. Downstream signals initiated in
mast cells by FceRI and other receptors. Curr. Opin. Immunol. 8:766–772.
Berridge, M.J. 1993. Inositol trisphosphate and calcium signaling. Nature. 361:
315–325.
Brown, A.M., A.J. O’Sullivan, and B.D. Gomperts. 1998. Induction of exocyto-
sis from permeabilized mast cells by the guanosine triphosphatases Rac and
Cdc42. Mol. Biol. Cell. 9:1053–1063.
Chen, H., and R. Padmanabhan. 1997. A simplified method of screening for iso-
lation of recombinant vaccinia virus. In Methods in Molecular Biology. R.
Tuan, editor. Humana Press, Inc., Totowa, NJ. 62:199–206.
Choi, O.H., J. Kim, and J. Kinet. 1996. Calcium mobilization via sphingosine ki-
nase in signaling by the FceRI antigen receptor. Nature. 380:634–636.
Choi, O.H., J.H. Lee, T. Kassessinoff, J.R. Cunha-Melo, S.V. Jones, and M.A.
Beaven. 1993. Antigen and carbachol mobilize calcium by similar mecha-
nisms in a transfected mast cell line (RBL-2H3 cells) that expresses m1 mus-
carinic receptors. J. Immunol. 151:5586–5595.
Chong, L.D., A. Traynor-Kaplan, G.M. Bokoch, and M.A. Schwartz. 1994. The
small GTP-binding protein Rho regulates a phosphatidylinositol 4-phos-
phate 5-kinase in mammalian cells. Cell. 79:507–513.
Elroy-Stein, O., and B. Moss. 1991. Expression of proteins in mammalian cells
using vaccinia viral vectors. Curr. Prot. Mol. Biol. 16.15.11–16.19.19.
Erickson, J.W., C. Zhang, R.A. Kahn, T. Evans, and R.A. Cerione. 1996. Mam-
malian Cdc42 is a brefeldin A-sensitive component of the Golgi apparatus. J.
Biol. Chem. 271:26850–26854.
Falasca, M., S.K. Logan, V.P. Lehto, G. Baccante, M.A. Lemmon, and J.
Schlessinger. 1998. Activation of phospholipase Cg by PI3-kinase-induced
PH domain-mediated membrane targeting. EMBO (Eur. Mol. Biol. Organ.)
J. 17:414–422.
Ferris, C.D., R.L. Huganir, S. Supattapone, and S.H. Solomon. 1989. Purified
inositol-1,4,5-trisphosphate receptor mediates calcium influx in reconsti-
tuted lipid vesicles. Nature. 342:87–89.
Guillemot, J., P. Montcourrier, E. Vivier, J. Davoust, and P. Chavrier. 1997. Se-
lective control of membrane ruffling and actin plaque assembly by the Rho
GTPases Rac1 and Cdc42 in FceRI-activated rat basophilic leukemia (RBL-
2H3) cells. J. Cell Sci. 110:2215–2225.
Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science. 279:509–514.
Hart, M.J., A. Eva, D. Zangrilli, S.A. Aaronson, T. Evans, R.A. Cerione, and
Y. Zheng. 1994. Cellular transformation and guanine nucleotide exchange
activity are catalyzed by a common domain on the dbl oncogene product. J.
Biol. Chem. 269:62–65.
Hartwig, J.H., G.M. Bokoch, C.L. Carpenter, P.A. Janmey, L.A. Taylor, A.
Toker, and T.P. Stossel. 1995. Thrombin receptor ligation and activated Rac
uncap actin filament barbed ends through phosphoinositide synthesis in per-
meabilized human platelets. Cell. 82:643–653.
Hoth, M., and R. Penner. 1992. Depletion of intracellular calcium stores acti-
vates a calcium current in mast cells. Nature. 355:353–356.
Howell, T.W., S. Cockcroft, and B.D. Gomperts. 1987. Essential synergy be-
tween Ca21 and guanine nucleotides in exocytotic secretion from permeabi-
lized rat mast cells. J. Cell Biol. 105:191–197.Hong-Geller and Cerione Cdc42 and Rac Activate IP3/Calcium Signaling 493
Illenberger, D., F. Schwald, and P. Gierschik. 1997. Characterization and purifi-
cation from bovine neutrophils of a soluble guanine-nucleotide-binding pro-
tein that mediates isozyme-specific stimulation of phospholipase C-b2. Eur.
J. Biochem. 246:71–77.
Illenberger, D., F. Schwald, D. Pimmer, W. Binder, G. Maier, A. Dietrich, and
P. Gierschik. 1998. Stimulation of phospholipase C-b2 by the Rho GTPases
Cdc42Hs and Rac1. EMBO (Eur. Mol. Biol. Organ.) J. 17:6241–6249.
Katakami, Y., K. Kaibuchi, M. Sawamura, Y. Takai, and Y. Nishizuka. 1984.
Synergistic action of protein kinase C and calcium for histamine release from
rat peritoneal mast cells. Biochem. Biophys. Res. Commun. 121:573–578.
Koffer, A., P.E.R. Tatham, and B.D. Gomperts. 1990. Changes in the state of
actin during the exocytotic reaction of permeabilized rat mast cells. J. Cell
Biol. 111:919–927.
Kuroda, S., M. Fukata, K. Kobayashi, M. Nakafuku, N. Nomura, A. Iwamatsu,
and K. Kaibuchi. 1996. Identification of IQGAP as a putative target for the
small GTPases, Cdc42 and Rac1. J. Biol. Chem. 271:23363–23367.
Lamarche, N., N. Tapon, L. Stowers, P.D. Burbelo, P. Aspenstrom, T. Bridges,
J. Chant, and A. Hall. 1996. Rac and Cdc42 induce actin polymerization and
G1 cell cycle progression independently of p65 PAK and the JNK/SAPK
MAP kinase cascade. Cell. 87:519–529.
Lelkes, P.I., J.E. Friedman, K. Rosenheck, and A. Oplatka. 1986. Destabiliza-
tion of actin filaments as a requirement for the secretion of catecholamines
from permeabilized chromaffin cells. FEBS Lett. 208:357–363.
Li, W., G.G. Deanin, B. Margolis, J. Schlessinger, and J.M. Oliver. 1992. FceRI-
mediated tyrosine phosphorylation of multiple proteins, including phospho-
lipase Cg1 and the receptor bg2 complex, in RBL-2H3 rat basophilic leuke-
mia cells. Mol. Cell Biol. 12:3176–3182.
Ludowyke, R.I., K. Kawasugi, and P.W. French. 1994. PMA and calcium iono-
phore induce myosin and F-actin rearrangement during histamine secretion
from RBL-2H3 cells. Cell. Motil. Cytol. 29:354–365.
Lytton, J., M. Westlin, and M.R. Hanley. 1991. Thapsigargin inhibits the sarco-
plasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J.
Biol. Chem. 266:17067–17071.
Mariot, P., A.J. O’Sullivan, A.M. Brown, and P.E.R. Tatham. 1996. Rho gua-
nine nucleotide dissociation inhibitor protein (RhoGDI) inhibits exocytosis
in mast cells. EMBO (Eur. Mol. Biol. Organ.) J. 15:6476–6482.
McCallum, S.J., W.J. Wu, and R.A. Cerione. 1996. Identification of a putative
effector for Cdc42Hs with high sequence similarity to the RasGAP-related
protein IQGAP1 and a Cdc42Hs binding partner with similarity to
IQGAP2.  J. Biol. Chem. 271:21732–21737.
Meisenhelder, J., P. Suh, S.G. Rhee, and T. Hunter. 1989. Phospholipase C-g is
a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo
and in vitro. Cell. 57:1109–1122.
Mignery, G.A., and T.C. Sudhof. 1990. The ligand binding site and transduction
mechanism in the inositol-1,4,5-trisphosphate receptor. EMBO (Eur. Mol.
Biol. Organ.) J. 9:3893–3898.
Norman, J.C., L.S. Price, A.J. Ridley, A. Hall, and A. Koffer. 1994. Actin fila-
ment organization in activated mast cells is regulated by heterotrimeric and
small GTP-binding proteins. J. Cell Biol. 126:1005–1015.
Norman, J.C., L.S. Price, A.J. Ridley, and A. Koffer. 1996. The small GTP-
binding proteins, Rac and Rho, regulate cytoskeletal organization and exo-
cytosis in mast cells by parallel pathways. Mol. Biol. Cell. 7:1429–1442.
O’Sullivan, A.J., A.M. Brown, H.N.M. Freeman, and B.D. Gomperts. 1996. Pu-
rification and identification of FOAD-II, a cytosolic protein that regulates
secretion in streptolysin-O permeabilized mast cells, as a Rac/RhoGDI com-
plex. Mol. Biol. Cell. 7:397–408.
Oberhauser, A.F., J.R. Monck, W.E. Balch, and J.M. Fernandez. 1992. Exocy-
totic fusion is activated by Rab3a peptides. Nature. 360:270–273.
Pfeiffer, J.R., J.C. Seagrave, B.H. Davis, G.G. Deanin, and J.M. Oliver. 1985.
Membrane and cytoskeletal changes associated with IgE-mediated seroto-
nin release from rat basophilic leukemia cells. J. Cell Biol. 101:2145–2155.
Pierini, L., D. Holowka, and B. Baird. 1996. FceRI-mediated association of
6-mm beads with RBL-2H3 mast cells results in exclusion of signaling pro-
teins from the forming phagosome and abrogation of normal downstream
signaling. J. Cell Biol. 134:1427–1439.
Prepens, U., I. Just, C. von Eichel-Streiber, and K. Aktories. 1996. Inhibition of
FceRI-mediated activation of rat basophilic leukemia cells by Clostridium
difficile toxin B (monoglucosyltransferase). J. Biol. Chem. 271:7324–7329.
Price, L.S., J.C. Norman, A.C. Ridley, and A. Koffer. 1995. The small GTPases
Rac and Rho as regulators of secretion in mast cells. Curr. Biol. 5:68–73.
Rhee, S.G., and Y.S. Bae. 1997. Regulation of phosphoinositide-specific phos-
pholipase C isozymes. J. Biol. Chem. 272:15045–15048.
Ross, C.A., J. Meldolesi, T.A. Milner, T. Satoh, S. Supattapone, and S.H. Sny-
der. 1989. Inositol 1,4,5-trisphosphate receptor localized to endoplasmic
reticulum in cerebellar Purkinje neurons. Nature. 339:468–470.
Sagi-Eisenberg, R., H. Lieman, and I. Pecht. 1985. Protein kinase C regulation
of the receptor-coupled calcium signal in histamine-secreting rat basophilic
leukemia cells. Nature. 313:59–60.
Sienaert, I., L. Missiaen, H. De Smedt, J.B. Parys, H. Sipma, and R. Casteels.
1997. Molecular and functional evidence for multiple Ca21-binding domains
in the type 1 inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 272:25899–
25906.
Toker, A. 1998. The synthesis and cellular roles of phosphatidylinositol 4,5-bis-
phosphate. Curr. Biol. 10:254–261.
Tolias, K.F., L.C. Cantley, and C.L. Carpenter. 1995. Rho family GTPases bind
to phosphoinositide kinases. J. Biol. Chem. 270:17656–17659.
Wilson, B.S., J.R. Pfeiffer, A.J. Smith, J.M. Oliver, J.A. Oberdorf, and R.J.H.
Wojcikiewicz. 1998. Calcium-dependent clustering of inositol 1,4,5-trisphos-
phate receptors. Mol. Biol. Cell. 9:1465–1478.
Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nono-
mura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortman-
nin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells.
J. Biol. Chem. 268:25846–25856.
Zheng, Y., S. Bagrodia, and R.A. Cerione. 1994. Activation of phosphoinosi-
tide 3-kinase activity by Cdc42Hs binding to p85. J. Biol. Chem. 269:18727–
18730.